We enable better health care.
Through superior and innovative low-temperature sterile reprocessing solutions for medical devices, we offer sterility and economic efficiency. This means better and more accessible medical care.
Our expertise and technology allows higher standards in sterile efficacy and materials compatibility. We aim to develop sterile reprocessing solutions to address challenging medical devices and enable the development of increasingly sophisticated devices and techniques.
Our sterile reprocessing solutions answer the global and growing need for economical and fast turnaround of a wide range of medical instruments, including cutting-edge, high-demand devices.
Founded in 1998, TSO3 originally developed a unique sterilization process based on only ozone as the sterilizing agent. It offered major savings over competing low-temperature sterilization methods, greater safety for both users and patients, and was considered a “green” technology.
The original 125L Ozone Sterilizer received regulatory clearances from both Health Canada and the United States Food and Drug Administration. The 125L Ozone Sterilizer also received additional clearances, expanding the field of application to a wider range of complex surgical instruments and attesting to the high sterilization efficacy of the TSO3 STERIZONE® sterilization platform.
In 2008, TSO3 welcomed new management team members with extensive experience in the sterilization industry. The team lead the development of a new generation sterilizer that would benefit from the already proven superior sterile efficacy of the STERIZONE® technology, while offering increased compatibility and speed and matching the market’s expectations for high-throughput of expensive and high-demand complex medical devices.